NutriBand (NTRB) Current Leases (2019 - 2026)
NutriBand (NTRB) posted Current Leases of $33201.0 for Q2 2026, up 2.3% sequentially from $32453.0 in Q1 2026, and up 9.54% YoY from $30309.0 in Q2 2025.
NutriBand (NTRB) Current Leases (2019 - 2026) Analysis & Trends
NutriBand has reported Current Leases for 8 years, with the latest figure at $33201.0 in Q2 2026.
- Quarterly Current Leases rose 9.54% year-over-year to $33201.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $33201.0 (up 9.54% YoY) and the FY2026 annual result came in at $32453.0, changed N/A from the prior year.
- Current Leases improved to $33201.0 in Q2 2026 per NTRB's latest filing, from $32453.0 in the prior quarter.
- Over five years, Current Leases peaked at $34276.0 in Q1 2024 and troughed at $8864.0 in Q4 2024.
- A 5-year average of $28131.4 and a median of $31291.0 in 2023 frame the typical range for Current Leases.
- The sharpest annual moves came in 2024 and 2025: Current Leases slumped 73.54% in 2024, then surged 257.87% in 2025.
- Over 5 years, Current Leases stood at $30586.0 in 2022, then gained by 9.54% to $33505.0 in 2023, then plunged by 73.54% to $8864.0 in 2024, then soared by 257.87% to $31722.0 in 2025, then advanced by 4.66% to $33201.0 in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $33201.0, $32453.0, and $31722.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | NutriBand | 57.74 Mn | 53.73 Mn | 196,801.00 | 33,201.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 33,201.00 |
| Jan 31, 2026 | 32,453.00 |
| Oct 31, 2025 | 31,722.00 |
| Jul 31, 2025 | 31,007.00 |
| Apr 30, 2025 | 30,309.00 |
| Oct 31, 2024 | 8,864.00 |
| Jul 31, 2024 | 17,528.00 |
| Apr 30, 2024 | 25,988.00 |
| Jan 31, 2024 | 34,276.00 |
| Oct 31, 2023 | 33,505.00 |
| Jul 31, 2023 | 32,750.00 |
| Apr 30, 2023 | 32,012.00 |
| Jan 31, 2023 | 31,291.00 |
| Oct 31, 2022 | 30,586.00 |
| Jul 31, 2022 | 19,526.00 |
| Apr 30, 2022 | 33,885.00 |
| Jan 31, 2022 | 19,331.00 |
| Oct 31, 2021 | 106,031.00 |
| Jul 31, 2021 | 25,506.00 |
| Apr 30, 2021 | 25,119.00 |